| 000 | 02613 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250513032539.0 | ||
| 264 | 0 | _c19951030 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0025-732X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aDrugs for AIDS and associated infections. _h[electronic resource] |
| 260 |
_bThe Medical letter on drugs and therapeutics _cOct 1995 |
||
| 300 |
_a87-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aAmphotericin B _xtherapeutic use |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAtovaquone |
| 650 | 0 | 4 |
_aCandidiasis, Oral _xdrug therapy |
| 650 | 0 | 4 |
_aClindamycin _xtherapeutic use |
| 650 | 0 | 4 |
_aClotrimazole _xtherapeutic use |
| 650 | 0 | 4 |
_aCryptosporidiosis _xdrug therapy |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdrug therapy |
| 650 | 0 | 4 |
_aDapsone _xtherapeutic use |
| 650 | 0 | 4 |
_aDidanosine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFluconazole _xtherapeutic use |
| 650 | 0 | 4 |
_aFlucytosine _xtherapeutic use |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aFoscarnet _xtherapeutic use |
| 650 | 0 | 4 |
_aGlucuronates _xtherapeutic use |
| 650 | 0 | 4 |
_aHerpes Simplex _xdrug therapy |
| 650 | 0 | 4 |
_aHerpes Zoster _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 |
_aItraconazole _xtherapeutic use |
| 650 | 0 | 4 |
_aKetoconazole _xtherapeutic use |
| 650 | 0 | 4 | _aLamivudine |
| 650 | 0 | 4 |
_aMycobacterium avium-intracellulare Infection _xdrug therapy |
| 650 | 0 | 4 |
_aNaphthoquinones _xtherapeutic use |
| 650 | 0 | 4 |
_aNystatin _xtherapeutic use |
| 650 | 0 | 4 |
_aPentamidine _xtherapeutic use |
| 650 | 0 | 4 |
_aPneumocystis Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPneumonia, Pneumocystis _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aPrimaquine _xtherapeutic use |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aStavudine _xtherapeutic use |
| 650 | 0 | 4 |
_aSyphilis _xdrug therapy |
| 650 | 0 | 4 |
_aToxoplasmosis _xdrug therapy |
| 650 | 0 | 4 |
_aTrimetrexate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 650 | 0 | 4 |
_aZalcitabine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aZidovudine _xadverse effects |
| 773 | 0 |
_tThe Medical letter on drugs and therapeutics _gvol. 37 _gno. 959 _gp. 87-94 |
|
| 999 |
_c7564752 _d7564752 |
||